Savoir Faire Capital Management L.P. Sells 14,692 Shares of Colgate-Palmolive Company (NYSE:CL)

Savoir Faire Capital Management L.P. lowered its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 63.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,598 shares of the company's stock after selling 14,692 shares during the period. Savoir Faire Capital Management L.P.'s holdings in Colgate-Palmolive were worth $806,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Resurgent Financial Advisors LLC raised its position in shares of Colgate-Palmolive by 5.8% in the 1st quarter. Resurgent Financial Advisors LLC now owns 5,278 shares of the company's stock worth $495,000 after acquiring an additional 287 shares in the last quarter. St. Louis Trust Co lifted its position in shares of Colgate-Palmolive by 45.5% during the first quarter. St. Louis Trust Co now owns 7,419 shares of the company's stock valued at $695,000 after buying an additional 2,319 shares during the last quarter. AMG National Trust Bank lifted its position in Colgate-Palmolive by 6.4% during the first quarter. AMG National Trust Bank now owns 9,426 shares of the company's stock valued at $883,000 after acquiring an additional 564 shares during the last quarter. Auxano Advisors LLC purchased a new stake in shares of Colgate-Palmolive during the 1st quarter valued at $432,000. Finally, Allegiance Financial Group Advisory Services LLC purchased a new stake in Colgate-Palmolive during the 1st quarter worth approximately $200,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Down 0.4%

Shares of NYSE:CL traded down $0.36 during trading on Friday, reaching $86.88. The stock had a trading volume of 4,973,724 shares, compared to its average volume of 4,867,631. Colgate-Palmolive Company has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock has a market cap of $70.41 billion, a P/E ratio of 24.54, a PEG ratio of 4.61 and a beta of 0.37. The business has a fifty day moving average price of $90.34 and a 200-day moving average price of $90.38. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.86 by $0.05. The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. Colgate-Palmolive's revenue for the quarter was down 3.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.86 earnings per share. As a group, analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a dividend of $0.52 per share. The ex-dividend date is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.39%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.76%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on CL shares. Piper Sandler cut their price objective on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research note on Monday, March 31st. UBS Group dropped their target price on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday. Citigroup increased their price target on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a report on Monday, April 28th. Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Finally, JPMorgan Chase & Co. upped their target price on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of "Hold" and an average target price of $100.64.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.